FREQUENCIES OF POLYMORPHISMS IN THE CYTOCHROME’S P450 GENES OF WARFARIN TRANSFORMATION IN A EUROPEAN POPULATION OF EASTERN SIBERIA

FREQUENCIES OF POLYMORPHISMS IN THE CYTOCHROME’S P450 GENES OF WARFARIN TRANSFORMATION IN A EUROPEAN POPULATION OF EASTERN SIBERIA

Background. Genotypes of the cytochrome p450 isoform (CYP2C9 and CYP4F2) determine warfarin dose requirements. Frequencies of risk alleles and genotypes of CYP2C9 and CYP4F2 gene vary in different races and ethnic groups.Aim. This study analyzed the frequencies of *2, *3 alleles of CYP2C9 gene and t...

Full description

Bibliographic Details
Main Authors:	T. A. Bairova, E. A. Novikova, F. I. Belyalov, E. A. Shchedreeva, K. D. Ievleva, O. V. Kalyuzhnaya, O. A. Ershova, V. G. Pustozerov, O. A. Kovaleva, I. V. Rasputina, I. A. Noskova, T. V. Batogova, O. V. Kuznetsova, O. Yu. Bogoslova, S. I. Kolesnikov
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2018-09-01
Series:	Acta Biomedica Scientifica
Subjects:	cyp2c9 cyp4f2
Online Access:	https://www.actabiomedica.ru/jour/article/view/705

Similar Items

Pharmacogenetic Warfarin Dosing Algorithm in the Russian Population
by: T. A. Bairova, et al.
Published: (2019-07-01)

PREVALENCE OF POLYMORPHOUS LOCUS 681G>A OF CYP2C19 GENE IN RUSSIAN POPULATION
by: T. A. Bairova, et al.
Published: (2014-11-01)

Pharmacogenetics of warfarin: A literature review
by: Nadezhda V. Izmozherova, et al.
Published: (2024-11-01)

Sensing the Generation of Intracellular Free Electrons Using the Inactive Catalytic Subunit of Cytochrome P450s as a Sink
by: Damilare D. Akintade, et al.
Published: (2020-07-01)

Tropoxine in the effective dose does not affect on activity of CYP2С9 and CYP1А2 isoforms of cytochrome P450 in rats
by: V. P. Zherdev, et al.
Published: (2017-11-01)

DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ASSAY OF SUBSTRATES-MARKERS OF MAIN CYTOCHROME P450 ISOFORMS AND THEIR METABOLITES USING HPLC-MS/MS
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study
by: Megan E. Solan, et al.
Published: (2023-01-01)

PREVALENCE OF 2756A>G POLYMORPHISM OF METHIONINE SYNTHASE GENE IN POPULATIONS OF EASTERN SIBERIA
by: K. D. Ievleva, et al.
Published: (2014-11-01)

Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes
by: D. V. Ivashchenko, et al.
Published: (2020-12-01)

SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson’s disease
by: Polina Petkova-Kirova, et al.
Published: (2024-09-01)

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin
by: O. A. Panibratiuk, et al.
Published: (2020-06-01)

Genotype of cytochrome-450 2C9 in patients with tuberculosis
by: Kresyun V.I., et al.
Published: (2013-06-01)

Augmentation of Pectoral Fin Teratogenicity by Thalidomide in Human Cytochrome P450 3A-Expressing Zebrafish
by: Wenjing Dong, et al.
Published: (2023-02-01)

New dual functional CYP450 gene involves in isoflavone biosynthesis in Glycine max L.
by: Yaying Xia, et al.
Published: (2023-03-01)

Molecular Dynamics Simulations of a Cytochrome P450 from <i>Tepidiphilus thermophilus</i> (P450-TT) Reveal How Its Substrate-Binding Channel Opens
by: Abayomi S. Faponle, et al.
Published: (2021-06-01)

Characterization and sexual dimorphic expression of Cytochrome P450 genes in gonads of the sea urchin (Mesocentrotus nudus)
by: Wei-Yi Su, et al.
Published: (2024-06-01)

Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons
by: Uppala Radhakrishna, et al.
Published: (2024-01-01)

Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024-05-01)

Interactions of Mycotoxin Alternariol with Cytochrome P450 Enzymes and OATP Transporters
by: Eszter Fliszár-Nyúl, et al.
Published: (2022-12-01)

Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms
by: O. G. Gribakina, et al.
Published: (2019-02-01)

Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies
by: Smarakan Sneha, et al.
Published: (2021-03-01)

Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs
by: Tyler C. Beck, et al.
Published: (2021-05-01)

Genetic risk factors of cytolysis syndrome in the treatment of recrudescence of chronic cardiovascular diseases
by: N. V. Kokh, et al.
Published: (2018-11-01)

CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation
by: A. A. Kurylev, et al.
Published: (2018-05-01)

Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
by: O. G. Gribakina, et al.
Published: (2020-04-01)

Mechanism of hepatoprotective action of methionine and composition “Metovitan” against a background of antituberculosis drugs administration to rats
by: S. I. Anisimova, et al.
Published: (2013-04-01)

Cytochrome P450 genes expression in human prostate cancer
by: Oksana Maksymchuk, et al.
Published: (2024-03-01)

Aspects of «Cocktail» cytochrome P450 activity determination methods application with the view of drug treatment rationalization
by: E. . Egorenkov, et al.
Published: (2020-04-01)

Cytochrome P-450 3A4 system in patients with acute myocardial infarction
by: A. G. Vladimirov, et al.
Published: (2008-08-01)

Cyp6g2 is the major P450 epoxidase responsible for juvenile hormone biosynthesis in Drosophila melanogaster
by: Qiangqiang Jia, et al.
Published: (2024-05-01)

Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast
by: Sangeeta Shrestha Sharma, et al.
Published: (2023-01-01)

Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism
by: Thien-Kim Le, et al.
Published: (2022-12-01)

The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches
by: P. N. Vlasov, et al.
Published: (2017-06-01)

Study of apolipoprotein C3 S1/S2 (C3238G, rs5128) polymorphism in Caucasian population of Eastern Siberia
by: O. V. Kalyuzhnaya, et al.
Published: (2014-09-01)

CLINICAL SIGNIFICANCE OF STUDYING GENETIC POLYMORPHISM OF THE Р450 CYP2C9 AND CYP2C19 DETOXIFYING ENZYME GENES IN EPILEPTIC CHILDREN
by: O. V. Guzeva, et al.
Published: (2016-05-01)

Role of Single Nucleotide Polymorphism of СУР17А Gene in the Development of Stroke
by: S. Yu. Nikulina, et al.
Published: (2018-09-01)

«COCKTAIL» METHODS OF CYTOCHROME P450 ISOFORMS ACTIVITY DETERMINATION <i>IN VIVO</i> USING BIOANALYTICAL METHODS: ACTUAL METHODS REVIEW AND OPPORTUNITIES OF THEIR APPLICATION IN CLINICAL PRACTICE
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

Association of the cytochrome P450 and arylamine N-acetyltransferase gene polymorphisms with the incidence of head and neck cancer in Polish population
by: Monika Gogolewska, et al.
Published: (2023-12-01)

Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk
by: Misheck Mudyiwa, et al.
Published: (2023-09-01)

Comparative assessment of prevalence of fibrinogen (-455)G>A gene polymorphism in teenagers from various populations of Eastern Siberia
by: A. Y. Senkina, et al.
Published: (2014-09-01)